Great news for pain and CNS management in RSA
Acino has collaborated with Janssen, the Pharmaceutical Company of Johnson & Johnson in South Africa, to enhance patient access to several medicines. Acino will now market and sell several of their products, focusing on pain, CNS (Central Nervous System) and Infectiology therapeutic areas in South Africa.
Recent Posts
Alzheimer’s Care Innovation: Advancing Implementation Across Europe
Pioneering Alzheimer's Care Innovation in Europe
Alzheimer's care innovation is transforming Europe's approach to the disease, shifting from policy discussions to real-world implementation of disease-modifying therapies. With 10 milli...
Long-Term Benefits of Composite Treatment Targets in Type 2 Diabetes Management
Sustained Composite Treatment Targets Enhance Clinical and Economic Outcomes in Type 2 Diabetes
A recent modeling study examines the long-term benefits of achieving
EU Medicine Authorizations 2025: A Milestone for Innovation and Accessibility
EU Medicine Authorizations 2025: A Year of Innovation
Advancements in EU Medicine Authorizations for 2025
In 2025, the European Medicines Agency (EMA) recommended 104 medicines for marketing authorisati...